Exhibit 99.1
External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com
 
 
Investor Relations & Media Contact:
Satya Chillara
(408) 213-0939
schillara@aemetis.com
 
Aemetis, Inc. Reports Third Quarter 2017 Financial Results
 
CUPERTINO, Calif. – November 9, 2017 -
Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the three and nine months ended September 30, 2017.
 
During the third quarter of 2017, year over year revenues for North America increased to $36.0 million from $33.9 million, while year over year revenues for India were lower due to the introduction of India’s Goods and Service Tax as well as a delay in the ramp up of India biodiesel deliveries to BP under a three-year supply agreement signed in the second quarter of 2017. Overall revenues decreased slightly during the third quarter of 2017 compared with the third quarter of 2016.
 
"During the third quarter of 2017, North America revenues grew 6.2% year over year," stated Eric McAfee, Chairman and CEO of Aemetis. “The production equipment installation and commissioning for the first phase of the patent-pending enzymatic biodiesel technology has been completed at our Kakinada plant and commercial yields have been achieved using low cost, low carbon feedstock. This production upgrade required more than two years of process development in cooperation with enzyme supplier Novozymes, resulting in a sustainable cost advantage in both domestic and export markets that in the fourth quarter of 2017 is expected to result in shipment increases to both BP and our existing bulk customers in India.”
 
Today, Aemetis will host an earnings review call at 11:00 am Pacific (PT).
 
For details on the call, visit: http://www.aemetis.com/investors/conference-call/
 
Financial Results for the Three Months Ended September 30, 2017
 
Revenues were $38.9 million for the third quarter of 2017, compared to $39.4 million for the third quarter of 2016. Revenue increased in North America to $36 million during the third quarter of 2017 from $33.9 million during the third quarter of 2016, but was offset by softer revenues from our India operating segment from a one-quarter delay in the expected start of the BP contract and overall softening of the domestic market demand with the introduction of Goods and Services Tax structure in India. Gross margin for the third quarter of 2017 was $2.0 million, compared to gross margin of $3.7 million during the third quarter of 2016. Weaker gross profit during the third quarter of 2017 compared to the same period of 2016 was primarily due to Brazilian imports of ethanol to California, which placed pricing pressure on West Coast ethanol, combined with sluggish international demand for dry distillers grains, which placed pricing pressure on locally sold wet distillers grain.
 
 
 
 
Research and development costs, including costs associated with the cellulosic ethanol initiative, particularly the operation of the Integrated Demonstration Unit, were $1.9 million for the third quarter of 2017, compared with expenses of $87 thousand during the same quarter of 2016.
 
Selling, general and administrative expenses remained constant at $3.2 million during the third quarters of both 2016 and 2017. Included in the selling, general and administrative expense for the third quarter of 2017 was $131 thousand of costs associated with Goodland Advanced Fuels, Inc.
 
Operating loss was $3.1 million for the third quarter of 2017, compared to an operating income of $357 thousand for the third quarter of 2016.
 
Net loss attributable to Aemetis, Inc. was $7.5 million for the third quarter of 2017, compared to a net loss of $4.1 million for the third quarter of 2016.
 
Interest expense during the third quarter of 2017 was $5.1 million, compared to $4.5 million during the third quarter of 2016. Included in interest expense for the third quarter of 2017 was $584 thousand of costs associated with Goodland Advanced Fuels, Inc.
 
Cash at the end of the third quarter of 2017 was $1.7 million compared to $1.5 million at the end of the fourth quarter of 2016.
 
Financial Results for the Nine Months Ended September 30, 2017
 
Revenues were $111.3 million for the first nine months of 2017, compared to $105.8 million for the first nine months of 2016. An increase in production at the Keyes plant resulted in an increase in ethanol and wet distiller’s grain volumes during the first nine months of 2017 compared to the first nine months of 2016. Gross profit for the first nine months of 2017 was $3.1 million, compared to $7.7 million during the first nine months of 2016. During the first nine months of 2017, gross profit decreased due to a softening price for wet distillers grains in a rising feedstock market compared to the same period of 2016. Additionally, gross margin during the first nine months of 2016 included a one-time grant benefit of $2 million for the usage of milo as a feedstock.
 
Selling, general and administrative expenses were $9.7 million during the first nine months of 2017, compared to $9.1 million during the first nine months of 2016. The increase in selling, general and administrative expenses was primarily attributable to salary increase, equity awards and marketing costs associated with the increase in gallons of ethanol sold in North America.
 
Operating loss was $8.7 million for the first nine months of 2017, compared to operating loss of $1.7 million for the first nine months of 2016.
 
Net loss attributable to Aemetis, Inc. was $22.0 million for the first nine months of 2017, compared to a net loss of $14.2 million during the first nine months of 2016.
 
Interest expense was $14.0 million during the first nine months of 2017, compared to interest expense of $12.9 million during the first nine months of 2016.
 
 
 
 
About Aemetis
 
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon-per-year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
 
NON-GAAP FINANCIAL INFORMATION
 
We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest expense, loss on extinguishment, income tax expense, intangible and other amortization expense, depreciation expense and share-based compensation expense.
 
Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison between companies.
 
Safe Harbor Statement
 
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, expectations for growth in India and development of our cellulosic ethanol business in North America.  Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “view,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2016, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
 
(Tables follow)
 
 
 
 
AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(unaudited, in thousands except per share data)
 
 
 
 
 
Three months ended
 
 
Nine months ended
 
 
 
September 30,
 
 
September 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Revenues
 $38,935 
 $39,377 
 $111,273 
 $105,762 
Cost of goods sold
  36,980 
  35,711 
  108,200 
  98,066 
Gross profit
  1,955 
  3,666 
  3,073 
  7,696 
 
    
    
    
    
Research and development expenses
  1,876 
  87 
  2,072 
  290 
Selling, general and administration expense
  3,182 
  3,222 
  9,739 
  9,123 
 
    
    
    
    
Operating income/(loss)
  (3,103)
  357 
  (8,738)
  (1,717)
 
    
    
    
    
Interest expense
    
    
    
    
Interest rate expense
  3,867 
  3,046 
  9,873 
  8,679 
Amortization expense
  1,265 
  1,425 
  4,112 
  4,269 
Other (income) expense
  (18)
  (19)
  2 
  (480)
Income/(loss before income taxes)
  (8,217)
  (4,095)
  (22,725)
  (14,185)
 
    
    
    
    
Income tax expense
  -- 
  -- 
  6 
  6 
 
    
    
    
    
Net income/(loss)
 $(8,217)
 $(4,095)
 $(22,731)
 $(14,191)
 
    
    
    
    
Net loss attributable to non-controlling interest entity
  (707)
  -- 
  (707)
  -- 
 
    
    
    
    
Net loss attributable to Aemetis, Inc.
 $(7,510)
 $(4,095)
 $(22,024)
 $(14,191)
 
    
    
    
    
 
    
    
    
    
Net income/(loss) per common share
    
    
    
    
Basic
 $(0.38)
 $(0.21)
 $(1.11)
 $(0.72)
Diluted
 $(0.38)
 $(0.21)
 $(1.11)
 $(0.72)
 
    
    
    
    
Weighted average shares outstanding
    
    
    
    
Basic
  19,804 
  19,833 
  19,760 
  19,741 
Diluted
  19,804 
  19,833 
  19,760 
  19,741 
 
 
 
 
AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)
 
 
 
September 30,
2017
(Unaudited)
 
 
December 31,
2016
 
Assets
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 $1,749 
 $1,486 
Accounts receivable
  2,199 
  1,557 
Inventories
  5,742 
  3,241 
Prepaid and other current assets
  2,950 
  761 
Total current assets
  12,640 
  7,045 
  Property, plant and equipment, net
  79,360 
  66,370 
Intangible and other assets
  4,331 
  4,395 
Total assets
 $96,331 
 $77,810 
 
    
    
Liabilities and stockholders' deficit
    
    
Current liabilities:
    
    
Accounts payable
 $9,367 
 $7,842 
Current portion of long term debt, notes and working capital
  14,559 
  11,409 
Mandatorily redeemable Series B convertible preferred stock
  2,920 
  2,844 
Other current liabilities
  6,970 
  5,121 
Total current liabilities
  33,816 
  27,216 
Total long term liabilities
  134,061 
  100,407 
Total Aemetis stockholders' deficit
  (70,839)
  (49,813)
Total Goodland Advanced Fuels, Inc. deficit
  (707)
  -- 
Total liabilities and stockholders' deficit
 $96,331 
 $77,810 
 
 
 
 
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
(unaudited, in thousands)
 
 
 
Three Months Ended
September 30,
 
 
 Nine Months Ended
September 30,
 
 
 
2017
 
 
2016  
 
 
2017  
 
 
2016
 
Net Income/(loss) attributable to Aemetis, Inc.
 $(7,510)
 $(4,095)
 $(22,024)
 $(14,191)
Adjustments:
    
    
    
    
Interest expense
  4,548 
  4,471 
  13,401 
  12,948 
Depreciation expense
  1,173 
  1,170 
  3,471 
  3,523 
Share-based compensation
  196 
  172 
  800 
  573 
Intangibles and other  amortization expense
  34 
  32 
  98 
  95 
Income tax expense
    
    
  6 
  6 
Total adjustments
  5,951 
  5,845 
  17,776 
  17,145 
Adjusted EBITDA
 $(1,550)
 $1,750 
 $(4,248)
 $2,954 
 
PRODUCTION AND PRICE PERFORMANCE
(unaudited)
 
 
 
Three months ended
September 30,
 
 
Nine months ended
September 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Ethanol
 
 
 
 
 
 
 
 
 
 
 
 
Gallons sold (in millions)
  15.4 
  14.8 
  44.5 
  41.0 
Average sales price/gallon
 $1.81 
 $1.75 
 $1.79 
 $1.74 
 
    
    
    
    
WDG
    
    
    
    
Tons sold (in thousands)
  104.7 
  97.2 
  300.2 
  277.3 
Average sales price/ton
 $66 
 $74 
 $63 
 $73 
 
    
    
    
    
Delivered cost of corn and milo
    
    
    
    
Bushels ground (in millions)
  5.5 
  5.2 
  15.8 
  14.4 
Average delivered cost / bushel
 $4.65 
 $4.45 
 $4.78 
 $4.58 
 
    
    
    
    
Biodiesel
    
    
    
    
Metric tons sold (in thousands)
  3.0 
  6.0 
  8.5 
  13.9 
Average Sales Price/Metric ton
 $837 
 $824 
 $873 
 $733 
 
    
    
    
    
Refined glycerin
    
    
    
    
Metric tons sold (in thousands)
  0.4 
  0.9 
  3.1 
  2.6 
Average Sales Price/Metric ton
 $905 
 $619 
 $770 
 $592 
 
 

The following information was filed by Aemetis, Inc (AMTX) on Thursday, November 9, 2017 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Aemetis, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aemetis, Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account